TheEdgeResearch
Home / Stocks / IGEX

Indo Global Exchange(s) PTE, Ltd. (IGEX)

OTC Healthcare Drug Manufacturers - Specialty & Generic
$0.00 ▼ -16.67%
Market Cap
$2.2M
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Beta
0.90
52-Wk Range
0.0002-0.0008
CEO
Sergio Bellosta Suarez
Country
US
Currency
USD

Indo Global Exchange(s) PTE, Ltd. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Deerfield, IL, US. The stock last traded at $0.00, down 16.67% on the session, giving a market capitalisation of $2.2M. On trailing twelve-month figures it carries a trailing P/E of -20.07, a net margin of 0.0%. Its beta of 0.90 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
-20.07
Price / Sales
0.00
Price / Book
0.71
EV / EBITDA
-18.48
Gross margin
0.0%
Operating margin
0.0%
Net margin
0.0%
Return on equity
Debt / equity
0.20
Current ratio
0.21
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
0
IPO date
2013-05-29
Headquarters
Deerfield, IL, US
About Indo Global Exchange(s) PTE, Ltd.

Indo Global Exchange(s) PTE, Ltd. is an early-stage firm focused on offering global investors access to financial markets. Utilizing its proprietary platform, the company provides connectivity to some 30 equity exchanges, facilitating transactions in both traditional securities and Contract for Difference (CFD) products. Its operations are headquartered in Jakarta, Indonesia.

Comparable companies

Indo Global Exchange(s) PTE, Ltd. is most often compared with the following Healthcare names:

CRYMCVGRFEVIOGENPFHEMPLVVVMCOANRPRPSYGFTLLTF
More research on IGEX
IGEX technical analysis IGEX TheEdge Score Compare against peers
Open full interactive analysis & DCF →